Stockholders' Equity (Details) - USD ($)		1 Months Ended								12 Months Ended
	May 15, 2020	Oct. 31, 2021	May 31, 2020	Apr. 30, 2020	Dec. 31, 2019	Aug. 31, 2019	Apr. 30, 2019	Jul. 31, 2017	Jun. 30, 2017	Dec. 31, 2021	Dec. 31, 2020	Oct. 25, 2021	Jun. 05, 2019	Jun. 04, 2019
Stockholders' Equity (Textual)
Issued shares of common stock	6,900,000		6,000,000	440,000		45,000
Common stock, per share						$ 17		$ 100
Issuance costs of offering								$ 176,771
Underwriting discounts and commissions and other offering expenses	$ 15,596,141			$ 1,522,339
Debt Issuance Costs, Net	$ 1,653,859			$ 347,661
Warrants issued										$ 707,188
Warrants to purchase of common stock								563
Common stock issued upon conversion								8,321
Exercise of stock options, Shares
Aggregate amount of conversion					$ 2,117,948
Common stock exercise price			$ 0.01
Shares of common stock	900,000
Common Stock, Shares Authorized										25,000,000	25,000,000		25,000,000	300,000,000
Options granted to purchase common stock			900,000
Common stock to the underwriter	300,000
Gross proceeds												$ 11,550,000
Offering expenses		$ 10,500,000
Description of purchase agreement		Pursuant to the terms of the Purchase Agreement, the Company issued to the investor (A) in a registered direct offering (i) 975,000 shares (the “Public Shares”) of its Common Stock, par value $0.01 per share (the “Common Stock”), and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 2,189,384 shares (the “Pre-Funded Warrant Shares”) of Common Stock and (B) in a concurrent private placement, Series A warrants to purchase up to 1,898,630 shares (the “Common Stock Warrant Shares”) of Common Stock (the “Common Stock Warrants,” and together with the Public Shares and the Pre-Funded Warrants, the “Securities”) (the “Offering The Pre-Funded Warrants were immediately exercisable at a nominal exercise price of $0.001 and all Pre-Funded Warrants sold have been exercised. The Common Stock Warrants have an exercise price of $4.80 per share, are exercisable upon issuance and will expire five years from the date of issuance. A.G.P./Alliance Global Partners (the “Placement Agent”) acted as the exclusive placement agent for the transaction pursuant to that certain Placement Agency Agreement, dated as of October 25, 2021, by and between the Company and the Placement Agent (the “Placement Agency Agreement”), the Placement Agent received (i) a cash fee equal to seven percent (7.0%) of the gross proceeds from the placement of the Securities sold by the Placement Agent in the Offering and (ii) a non-accountable expense allowance of one half of one percent (0.5%) of the gross proceeds from the placement of theGross Proceeds Securities sold by the Placement Agent in the Offering. The Company also reimbursed the Placement Agent’s expenses up to $50,000 upon closing the Offering.
Purchase Agreement [Member]
Stockholders' Equity (Textual)
Issued shares of common stock							42,388
Common stock, per share							$ 22
Issuance costs of offering							$ 379,816
Warrants to purchase of common stock							4,239
IPO [Member]
Stockholders' Equity (Textual)
Issued shares of common stock					857,500	2,250		11,250	75,000
Common stock, per share			$ 2.5	$ 4.25	$ 3				$ 100
Issuance costs of offering					$ 454,552				$ 1,388,615
Warrants issued									$ 3,750
Issued warrants									55,475
Common stock issued upon conversion								90,084
Common Stock Issued Under Underwriting Agreement [Member]
Stockholders' Equity (Textual)
Issuance costs of offering						$ 181,695
New Preferred Stock [Member]
Stockholders' Equity (Textual)
Issued shares of common stock								25,833